NDC11 00069045430
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00069-0454-30 | 00069-0454 |
| 00069-454-30 | 00069-454 |
| 0069-0454-30 | 0069-0454 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Talzenna | TALAZOPARIB | Pfizer Laboratories Div Pfizer Inc | c6fd147f-a77e-4a0b-9280-e82ecc41b4be | 2026-04-10 | Warnings, Adverse reactions | 0069-0454-30 0069-0454 00069045430 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.